GlassScriptPhysician profile
Hugo O Rosero
NPI 1346224441
$13,302.32
in general payments reported to CMS, 2019-2025
23 companies · $2,166 in 2025
The $2,166 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,606 · 2020: $1,219 · 2021: $973 · 2022: $2,218 · 2023: $2,875 · 2024: $1,246 · 2025: $2,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,286.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,536.53 | 2019-2025 | 2cm Peripheral Cutting Balloon, Interlock, General - Therapies |
| Shockwave Medical, INC | $2,651.84 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $2,001.84 | 2019-2025 | Rotarexs 6 F X 135 Cm, Venovo, Lutonix Drug Coated Balloon |
| Abbott Laboratories | $1,510.85 | 2019-2025 | Dragonfly Opstar, Diamondback Coronary, Xience Skypoint |
| Bolton Medical INC | $721.60 | 2019-2020 | |
| Cardiovascular Systems INC. | $662.77 | 2019-2021 | |
| Philips North America LLC | $609.84 | 2019-2025 | Igt Devices Undivided |
| Abiomed | $313.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.41 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $174.53 | 2020-2025 | |
| Medtronic, INC. | $155.11 | 2021 | |
| Penumbra, INC. | $148.00 | 2022 | |
| Merck Sharp & Dohme LLC | $136.06 | 2023 | Verquvo, Belsomra |
| Ge Healthcare | $112.41 | 2021 | |
| Esperion Therapeutics, INC. | $80.54 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $63.40 | 2021 | |
| Imperative Care, INC | $48.62 | 2025 | Prodigy Catheter |
| Janssen Pharmaceuticals, INC | $45.38 | 2022 | |
| Chiesi USA, INC. | $31.30 | 2024-2025 | Kengreal |
| Pfizer INC. | $24.88 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.36 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.97 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugo Rosero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.